Non-Coding RNAs as Critical Modulators of Cholesterol Metabolism in Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cholesterol metabolism reprogramming is crucial for tumor cells' high energy and biosynthetic demands.
• Elevated cholesterol levels are linked to increased risks for breast, prostate, and colorectal cancers.
• Dysregulated cholesterol metabolism is implicated in cancer development and progression.

Purpose of the Study:

• To systematically review the role of non-coding RNAs (ncRNAs) in regulating cholesterol metabolism within cancer.
• To provide a comprehensive overview of how ncRNAs influence tumor progression via cholesterol metabolism.
• To identify potential therapeutic targets for cancer treatment based on ncRNA-mediated cholesterol regulation.

Main Methods:

• Literature review and synthesis of existing research on ncRNAs and cholesterol metabolism in cancer.
• Analysis of ncRNA functions, including miRNAs, lncRNAs, circRNAs, piRNAs, and tRNAs.
• Examination of ncRNA impact on cancer hallmarks: growth, metastasis, drug resistance, and immune evasion.

Main Results:

• ncRNAs, including miRNAs, lncRNAs, circRNAs, piRNAs, and tRNAs, are key regulators of cholesterol metabolism in cancer.
• Cholesterol metabolism reprogramming influences tumor growth, metastasis, drug resistance, and immune evasion.
• Specific ncRNAs have been identified that modulate cholesterol pathways critical for cancer progression.

Conclusions:

• ncRNAs play a significant role in governing cholesterol metabolism in various cancers.
• Understanding ncRNA-mediated cholesterol regulation offers novel therapeutic strategies for cancer treatment.
• Targeting ncRNAs involved in cholesterol metabolism presents a promising avenue for future cancer therapies.